SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-17-000030
Filing Date
2017-05-09
Accepted
2017-05-09 16:23:25
Documents
64
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q halo1q2017-10q.htm 10-Q 925372
2 EXHIBIT 31.1 ex311q12017.htm EX-31.1 17197
3 EXHIBIT 31.2 ex312q12017.htm EX-31.2 17245
4 EXHIBIT 32 ex32q12017.htm EX-32 19992
11 slide1a28.jpg GRAPHIC 344752
12 slide2a23.jpg GRAPHIC 344017
13 slide3a22.jpg GRAPHIC 233818
  Complete submission text file 0001159036-17-000030.txt   6237587

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT halo-20170331.xml EX-101.INS 973114
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20170331.xsd EX-101.SCH 41421
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20170331_cal.xml EX-101.CAL 66326
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20170331_def.xml EX-101.DEF 160925
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20170331_lab.xml EX-101.LAB 526742
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20170331_pre.xml EX-101.PRE 285884
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 17826759
SIC: 2836 Biological Products, (No Diagnostic Substances)